For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market.
The report is available by section, and can be customized to specific information needs and budget.
Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe/Hologic, Tecan, Trinity Biotech and other manufacturers.
The report also presents strategic assessments of current and emerging suppliers of molecular diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 103 pages